¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Foodborne pathogens and disease."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • respiratory disease
    È£Èí±âÁúȯ
  • reversible obstructive lung disease
    °¡¿ªÆó¼âÆóº´, °¡¿ªÆó¼âÆóÁúȯ
  • rheumatic disease
    ·ù¸¶Æ¼½ºº´
  • rheumatoid disease
    ·ù¸¶Æ¼½º¸ð¾çÁúȯ
  • rice disease
    ½Òº´, °¢±âº´
  • rickettsial disease
    ¸®ÄÉÂ÷º´
  • Ritter¡¯s disease
    ¸®Åͺ´
  • rolling disease
    ȸÀüº´
  • spinocerebellar disease
    ô¼ö¼Ò³úº´
  • spirochetal disease
    ½ºÇÇ·ÎÇ쟺´
  • sterility disease
    ºÒÀÓº´
  • Schilder disease
    ½Ç´õº´
  • storage disease
    ÃàÀûº´
  • systemic disease
    Àü½Åº´
  • secondary disease
    ¼Ó¹ßº´, ¼Ó¹ßÁúȯ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • storage disease
    ÃàÀûº´
  • subclinical disease
    ºÒÇö¼ºº´
  • systemic disease
    Àü½Åº´
  • thoracic disease
    °¡½¿º´, ÈäºÎÁúȯ
  • tick-borne disease
    Áøµå±â¸Å°³º´
  • trophoblastic disease
    ¿µ¾ç¸·º´
  • tropical disease
    ¿­´ëº´
  • tsutsugamushi disease
    ÂêÂê°¡¹«½Ãº´
  • tubulointerstitial disease
    ¿ä¼¼°ü»çÀÌÁúÁúȯ, ¿ä¼¼°ü°£Áúº´
  • upper respiratory disease
    »ó±âµµº´
  • uremic medullary cystic disease
    ¿äµ¶¼ÓÁú³¶º´
  • valvular heart disease
    ÆÇ¸·½ÉÀ庴
  • vascular disease
    Ç÷°üº´
  • venereal disease
    ¼ºº´
  • veno-occlusive disease
    Á¤¸ÆÆó¼âº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • hartnup disease
    ÇÏ¾ÆÆ®´¯ º´, Hartnup º´
  • heart disease
    ½ÉÁúȯ(ãýòðü´), ½ÉÀ庴(ãýíôÜ»).
  • heart muscle disease
    ½É±ÙÁúȯ(ãýÐÉòðü´)
  • heart water disease
    ½É¼öº´(ãýâ©Ü»).
  • heavy chain disease
    H¼âº´(¡­áðÜ»), Á߼⺴(ñìáðÜ»).
  • heavy chain disease
    Áß ¼âº´
  • heavy-chain disease
    Á߼⺴
  • helminthiasis =helminthic disease
    À±Ã溴(ëÌõùÜ»).
  • helminthic disease
    À±Ã漺 Áúȯ(ëÌõùàõ òðü´)
  • hematopoietic disease
    Á¶Ç÷¼º Áúȯ.
  • hemic disease
    Ç÷¾×Áúȯ(úìäûòðü´).
  • hemisoimmune disease
    ÀûÇ÷±¸µ¿Á¾¸é¿ªÁúȯ.
  • hemoglobin C disease
    Çì¸ð±Û·Îºó Cº´.
  • hemoglobin C disease
    Çì¸ð±Û·Îºó C º´
  • hemoglobin C disease
    Çì¸ð±Û·Îºó C º´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • buffalo disease
    ¹°¼Ò³ú¿°(¡­Òàæú).
  • bullous disease
    ¼öÆ÷¼º Áúȯ(â©øÞàõ òðü´)
  • bullous disease
    ¼öÆ÷¼º Áúȯ
  • cadmium workers disease
    Ä«µå¹ÅÁ÷°øº´(ÊṲ̀˭ËÓ).
  • caisson disease
    ÀáÇÔº´(íÖùæÜ»)
  • caisson disease
    ÀáÇÔº´(íÖùÞÜ»), Àá¼öº´(íÖâ©Ü»)
  • caisson disease =decompression sickness
    ÀáÇÔº´(Ëö̰ËÓ)ÊÙ°¨¾Ðº´ÊÙ.
  • calcific mitral disease
    ¼®È¸È­½Â¸ðÆÇ¸·Áúȯ(à´üéûùã¬Ù¶÷ýدòðü´).
  • calcific mitral disease
    ¼®È¸È­½Â¸ðÆÇ¸·Áúȯ(¡­ã¬Ù¶÷ûدòðü´).
  • calomel disease
    °¨È«º´
  • caloric disease
    °í¿Âº´(ÍÔè®Ü»).
  • caloric disease
    °í¿Âº´(Ë­ËíËÓ).
  • canavans disease
    Ä«³ª¹Ý º´ (¡­Ü»)
  • carcinoid heart disease
    Ä«¸£½Ã³ëÀÌµå ½ÉÁúȯ( -ãýòðü´).
  • carcinoid heart disease
    Ä«¸£½Ã³ëÀÌµå ½ÉÁúȯ (¡­ãýòðü´)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
CHAD cold hemagglutinin disease; cyclophosphamide, hexamethylmelamine, Adriamycin (doxorubicin), and cisp...
CPD calcium pyrophosphate deposition; cephalopelvic disproportion; cerebelloparenchymal disorder; childh...
FMD facility medical director; family medical doctor; fibromuscular dysplasia; foot and mouth disease; f...
FMDV foot and mouth disease virus
HAM hearing aid microphone; helical axis in motion; human albumin microsphere; human alveolar macrophage...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
CAD Coronary Artery Disease
CHD Coronary Heart Disease
CD Cowden Disease
CD Crohn Disease
CDAI Crohn Disease Activity Index
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Raynaud's disease
    ·¹ÀÌ³ë º´
    ¿ø¹ß¼º ¶Ç´Â Ư¹ß¼º Ç÷°ü Àå¾Ö·Î ¾çÃøÀÇ ·¹À̳ë Çö»óÀÇ ¹ßÀÛÀÌ Æ¯Â¡. ³²¼ºº¸´Ù´Â ¿©¼ºÀÌ ¹ßº´Çϱ⠽±´Ù.
  • reactive disease
    ¹ÝÀÀ¼º Áúȯ
  • Recklinghausen's disease
    Recklinghausen º´
    ´Ù¹ß, ´ÙÇü¼º ½Å°æ ¼¶À¯Á¾À̸ç, ±× ¹Û¿¡µµ »À, ÁßÃß ½Å°æ, ÀÚÀ² ½Å°æ µî¿¡µµ Á¾·ù¸¦ Çü¼ºÇÏ´Â ÇϳªÀÇ µ¶¸³ ÁúȯÀÌ´Ù. º´¸íÀº µ¶ÀÏÀÇ º´¸®ÇÐÀÚ F.D.von ·¹Å¬¸µÇÏ¿ìÁ¨
  • Refsum's disease
    ·¹ÇÁ¼¶ º´
    ÆÄÀÌź»ê
  • renal atheroembolic disease
    ½ÅÁ×»ó Àü»öº´, ½ÅÁ×Á¾ »öÀüº´
  • renal disease
    ½Å Áúȯ
  • Rendu Osler Weber disease
    ·»µÎ ¿À½½·¯ ¿þ¹ö º´
  • restrictive heart disease
    ±¸¼Ó¼º ½É Áúȯ
  • restrictive pulmonary disease
    ±¸¼Ó¼º Æó Áúȯ
  • retimal degenerative disease
    ¸Á¸· ÅðÇ༺ Áúȯ
    ±¹¼Ò ¸ð¼¼ Ç÷°ü °æÈ­¿Í ±¸¸Û Çü¼º°ú ÇÔ²² ¸Á¸· ÃÊÀÚü Á¢Ã˸éÀ» ħ¹üÇϰųª ¶Ç´Â ¸Á¸· ÃÊÀÚü À¯Âø°ú ÃÊÀÚü ¾×È­°¡ ¸Á¸· °ßÀÎ, ¸Á¸·ÀÇ ¸»±Á ¸ð¾ç ÆÄ¿­, ±×¸®°í ¹Ú¸®¸¦ ÀÏÀ¸Å°´Â ºÐ¸®µÈ ºÎÀ§·Î¼­ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
  • rheumatic disease
    ·ù¸¶Æ¼¼º Áúȯ, ·ù¸¶Æ¼½º¼º Áúȯ
  • rheumatic valvular disease
    ·ù¸¶Æ¼½º¼º ÆÇ¸· Áúȯ
  • rheumatoid disease
    ·ù¸¶Æ¼½º¾ç Áúȯ
    Ư¡À¸·Î¼­ Ȱ¸·¿°. °üÀý ÆÄ±«, °üÀý º¯Çü µîÀÇ °üÀýħ½ÀÀ» ÁÖ·Î ÇÏ´Â Àü½Å¼º Áúȯ.
  • Riga-Fede disease
    ¸®°¡-Æäµ¥º´
    ¼Ò¾ÆÀÇ ¼³¼Ò´ëÀÇ À°¾ÆÁ¾À¸·Î ÇÏ¾Ç ÁßÀýÄ¡¿¡ ÀÇÇÑ ¸¶Âû ÈÄ¿¡ »ý±ä´Ù.
  • saccharine disease
    »çÄ«¸° º´
    ½ÄÀ̼º ¼¶À¯¿Í ´Ü¹éÁúÀ» Á¦°ÅÇϰí Á¤Á¦ÇÑ ÇÔ¼öź¼Ò ½Ä»ç¸¦ °úµµÇÏ°Ô ¼·ÃëÇÏ¿© »ý±â´Â Áúº´¿¡ ´ëÇÏ¿© Á¦Ã¢µÈ ¿ë¾îÀÌ´Ù. À̰Ϳ¡´Â ´ç´¢º´, ½ÉÇ÷°ü Áúȯ, º¯ºñ, ºñ¸¸Áõ ¹× ¼ÒÈ­¼º ±Ë¾ç µîÀÌ Æ÷ÇԵȴÙ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
united states occupational safety and health administration An office in the department of labour responsible for developing and establishing occupational safety and health standards.
(12 Dec 1998)
united states substance abuse and mental health services administration An agency of the public health service concerned with the overall planning, promoting, and administering of programs pertaining to substance abuse and mental health. It is commonly referred to by the acronym samhsa. On 1 october 1992, the united states alcohol, drug abuse, and mental health administration (adamha) became samhsa. (telephone communication with samhsa 7 april 1992)
(12 Dec 1998)
feeding and eating disorders of childhood Mental disorders related to feeding and eating that are usually diagnosed in infancy or early childhood.
(12 Dec 1998)
fees and charges Amounts charged to the patient as payer for health care services.
(12 Dec 1998)
fellowships and scholarships Stipends or grants-in-aid granted by foundations or institutions to individuals for study.
(12 Dec 1998)
ferric and ammonium acetate solution A clear, aromatic, reddish-brown liquid which has been used in iron-deficiency anaemia in animals and man; a source of iron.
Synonym: Basham's mixture.
(05 Mar 2000)
urologic and male genital diseases A collective term for urinary tract diseases in male and female and diseases of the male genitalia.
(12 Dec 1998)
figure and ground That aspect of perception wherein the perceived is separated into at least two parts, each with different attributes but influencing one another. Figure is the most distinct; ground the least formed; e.g., a bird or tree (figure) seen against the sky (ground).
(05 Mar 2000)
Fitz-Hugh and Curtis syndrome <syndrome> Perihepatitis in women with a history of gonococcal or chlamydial salpingitis.
(05 Mar 2000)
floors and floorcoverings The surface of a structure upon which one stands or walks.
(12 Dec 1998)
laboratory techniques and procedures Methods, procedures, and tests performed in the laboratory with an intended application to the diagnosis of disease or understanding of physiological functioning. The techniques include examination of microbiological, cytological, chemical, and biochemical specimens, normal and pathological.
(12 Dec 1998)
fluids and secretions Liquid substances produced by living organisms to fulfill specific functions or excreted as waste. Secretions do not include hormones or enzymes.
(12 Dec 1998)
focal and segmental hyalinosis <nephrology> A kidney disorder that results in fibrosis and scarring in the kidney glomerulus. The cause is unknown but some cases can result from reflux nephropathy. The clinical manifestation of this kidney disorder is nephrotic syndrome.
Symptoms include weight gain, swelling, hypertension and foamy urine. High blood cholesterol and triglyceride levels are also seen with this disorder. Treatment has included the use of corticosteroids and immunosuppressives. Antihypertensive agents and diuretics may also be necessary. Over one-half will develop chronic renal failure within 10 years of diagnosis.
(27 Sep 1997)
lanatosides A, B, and C Digilanides A, B, and C; the cardioactive precursor glycosides obtained from Digitalis lanata. Removal of the acetyl group yields desacetyllanatosides A, B, and C (purpurea glycosides A, B, and C, respectively); removal of the glucose from lanatosides A, B, and C yields acetyldigitoxin, acetylgitoxin, and acetyldigoxin, respectively; removal of glucose and the acetyl group yields digitoxin, gitoxin, and digoxin, respectively.
See: purpurea glycosides A.
(05 Mar 2000)
food and beverages Edible or potable substances.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á